F3. Joint ventures and associates

AP ACCOUNTING PRINCIPLES

Joint arrangements

SCA classifies its joint arrangements as joint ventures or joint operations, which are presented in further detail in Note F4.

Joint ventures

Joint ventures are defined as companies in which SCA together with other parties, through an agreement, has shared control over operations. A joint venture entitles the joint owners to the net assets of the investment. Joint ventures are recognized in accordance with the equity method, meaning that a net item including the goodwill will be recognized for each joint venture in the balance sheet. A share in profits is recognized in the income statement as “profit from holdings in joint ventures.” Share in profits is calculated on the basis of SCA’s share of equity in the respective joint venture. Joint arrangements recognized in accordance with the equity method are initially measured at cost. Measurement of acquired assets and liabilities is carried out in the same way as for subsidiaries. SCA’s single largest joint venture is Bunzl & Biach Gesellschaft m.b.H., Vienna, which supplies the hygiene business with raw materials.

Associates

Associates are companies in which the Group exercises a significant influence without the partly owned company being a subsidiary or a joint arrangement. Normally, this means that the Group owns between 20% and 50% of the votes. Accounting for associates is carried out according to the equity method and the companies are initially measured at cost. Valuation of acquired assets and liabilities is performed in the same manner as for subsidiaries and the carrying amount for associates includes any goodwill and other Group adjustments.

The Group’s share of profit after tax arising in the associate after the acquisition is recognized on one line in the consolidated income statement. Share in profits is calculated on the basis of SCA’s share of equity in the respective associate. Asaleo Care in Australia was reclassified as an associate when SCA decreased holding following the company’s flotation on the Australian stock exchange.

Carrying amounts of joint ventures and associates

SEKm

2015

2014

2013

1)

Net increase for the period includes the Group’s share of the profit after tax of joint ventures and associates, as well as items recognized directly in equity (both after deductions for any non-controlling interests), in addition to an adjustment for dividends received during the period, which amounted to SEK 11m (10; 27) for joint ventures and SEK 125m (16; 30) for associates.

Joint ventures

 

 

 

Value, January 1

122

837

771

Investments

129

10

Net increase in joint ventures 1)

4

–165

–49

Remeasurement effect upon changes in holdings

46

Reclassification between subsidiaries and joint ventures

37

Reclassification between joint ventures and associates

–8

–719

Translation differences

–4

40

22

Value, December 31

114

122

837

 

 

 

 

Associates

 

 

 

Value, January 1

966

183

1,486

Investments

68

1

Company acquisitions

58

Company divestments

–13

Net increase in associates 1)

41

101

104

Impairment of associates

–62

Reclassification between associates and subsidiaries

–7

–72

–1,454

Reclassifications due to changes in the acquisition balance sheet

–11

Reclassification between joint ventures and associates

8

719

Translation differences

–50

46

1

Value, December 31

964

966

183

BS TF3:1 Value, December 31, joint ventures and associates

1,078

1,088

1,020

Joint ventures and associates

Recognized joint ventures and associates mainly operate in the forest products industry, with the exception of Vinda and Asaleo Care Ltd, which operate in tissue and personal care products.

Asaleo Care Ltd

As of 2014, Asaleo Care Ltd in Australia is recognized as an associate in accordance with the equity method, following the flotation of the company on the Australian Securities Exchange (ASX). In connection with the flotation, SCA’s participation decreased to 32.5%. In 2015, the company implemented a program to repurchase shares from the market, in which SCA did not participate. This caused SCA’s participation in Asaleo Care to increase to 34.7% during the fourth quarter. Asaleo Care manufactures and markets consumer tissue and AfH tissue, baby diapers, feminine care products and incontinence products. SCA has licensed its Tork and TENA brands to Asaleo Care for sale in Australia, New Zealand and Fiji.

Vinda

In 2013, SCA acquired additional participations in Vinda and the company became a subsidiary, in which SCA currently has a holding of 51.4%. The company primarily operates in the markets in Hong Kong, Macau and China. Refer also to Note F2.

Bunzl & Biach

Bunzl & Biach is a joint venture that operates in the recovered paper market and supplies raw materials to SCA’s hygiene business.

TF3:1 Joint ventures and associates, 100% of operations

 

Joint ventures

 

Associates

 

 

 

 

Bunzl & Biach

 

Asaleo Care Ltd

 

Vinda

Total

SEKm

2015

2014

2013

 

2015

2014

2013 1)

 

 

 

2013 2)

2015

2014

2013

1)

Asaleo Care was recognized as a joint venture in 2013. Following the stock market flotation in 2014, the company was classified as an associate since SCA’s holding decreased.

2)

SCA increased its holding in the company Vinda at year-end 2013 to 51.4% of the votes in the company. As a result, the company was reclassified from being consolidated as an associate to being consolidated as a subsidiary.

Condensed income statement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

852

776

719

 

3,946

3,890

3,943

 

 

 

5,706

4,798

4,666

10,368

Depreciation/amortization

–11

–9

 

–169

–154

–172

 

 

 

–9

–180

–163

–181

Operating profit

31

20

16

 

736

375

486

 

 

 

598

767

395

1,100

Interest income

 

3

 

 

 

3

3

3

Interest expense

 

–64

–153

–231

 

 

 

–51

–64

–153

–282

Other financial items

3

1

1

 

–3

–208

–54

 

 

 

37

–207

–16

Tax expense

–8

–6

–4

 

–193

5

–56

 

 

 

–109

–201

–1

–169

Profit for the period

26

16

13

 

479

18

145

 

 

 

456

505

34

614

Other comprehensive income for the period

–1

 

–49

106

79

 

 

 

118

–50

106

197

Comprehensive income for the period

25

16

13

 

430

124

224

 

 

 

574

455

140

811

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed balance sheet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets

106

53

56

 

3,343

3,555

3,020

 

 

 

 

3,449

3,608

3,076

Current investments

 

 

 

 

 

Cash and cash equivalents

10

55

43

 

214

226

314

 

 

 

 

224

281

357

Other current assets

93

98

89

 

1,159

1,161

998

 

 

 

 

1,252

1,259

1,087

Total assets

209

206

188

 

4,716

4,942

4,332

 

 

 

 

4,925

5,148

4,520

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current financial liabilities

50

48

52

 

1,792

1,723

2,413

 

 

 

 

1,842

1,771

2,465

Other non-current liabilities

47

46

39

 

181

78

239

 

 

 

 

228

124

278

Current financial liabilities

 

24

5

18

 

 

 

 

24

5

18

Other current liabilities

16

18

9

 

668

658

711

 

 

 

 

684

676

720

Total liabilities

113

112

100

 

2,665

2,464

3,381

 

 

 

 

2,778

2,576

3,481

Net assets

96

94

88

 

2,051

2,478

951

 

 

 

 

2,147

2,572

1,039

Group share of net assets

47

46

43

 

711

806

476

 

 

 

 

758

852

519

Fair value adjustment

56

66

51

 

119

43

258

 

 

 

 

175

109

309

Carrying amount of the companies

103

112

94

 

830

849

734

 

 

 

 

933

961

828

Carrying amount of other joint ventures

 

 

 

 

 

 

 

 

 

 

 

11

10

9

Carrying amount of other associates

 

 

 

 

 

 

 

 

 

 

 

134

117

183

BS TF3:2 Carrying amount of joint ventures and associates

 

 

 

 

 

 

 

 

 

 

 

1,078

1,088

1,020

Market value, December 31

 

 

 

 

5,495

6,402

 

 

 

 

10,834

 

 

 

TF3:2 Carrying amounts of joint ventures and associates

Company name

Corp. Reg. No.

Domicile

Share of equity at December 31, 2015, %

Share of equity at December 31, 2014, %

Share of equity at December 31, 2013, %

Carrying amount at December 31, 2015, SEK m

Carrying amount at December 31, 2014, SEK m

Carrying amount at December 31, 2013, SEK m

Joint ventures

 

 

 

 

 

 

 

 

Bunzl & Biach GmbH

FN79555v

Vienna, Austria

49

49

49

103

112

94

Asaleo Care Ltd

61 154 461 300

Melbourne, Australia

50

734

Other

 

 

 

 

 

11

10

9

 

 

 

 

 

 

 

 

 

Associates

 

 

 

 

 

 

 

 

Asaleo Care Ltd

61 154 461 300

Melbourne, Australia

35

33

830

849

Other

 

 

 

 

 

134

117

183

BS TF3:1 Carrying amount, December 31

 

 

 

 

 

1,078

1,088

1,020